Keyphrases
Immunomodulatory Effect
100%
Type I Interferon Signaling
100%
Kinase Inhibitor
100%
Imatinib
100%
Immune System
50%
Tumor Growth
50%
Tumor Cells
50%
Mouse Model
50%
Type I Interferon
50%
Signaling Pathway
50%
Pathway Inhibitors
50%
Interferon Production
50%
Immune Regulation
50%
Gastrointestinal Stromal Tumor
50%
Interferon Signaling
50%
Type I Interferon Response
50%
Cell-less
50%
Tumor Immune Surveillance
50%
Validated Approach
50%
Medicine and Dentistry
Phosphotransferase Inhibitor
100%
Imatinib
100%
Interferon Type I
100%
Immunosuppressive Drug
100%
Malignant Neoplasm
50%
Neoplasm
50%
Tumor Progression
50%
Cell Signaling Pathway
50%
Tumor Cell
50%
Immune System
50%
Immunity
50%
Gastrointestinal Stromal Tumor
50%
Kinase
50%
Interferon Production
50%
Immunotherapy
50%
Immunosurveillance
50%
Immunology and Microbiology
Interferon Type I
100%
Immunosuppressive Drug
100%
Immunosurveillance
50%
Mouse Model
50%
Immunity
50%
Agonist
50%
Immune System
50%
Interferon Production
50%
Tumor Cell
50%
Immunotherapy
50%
Pharmacology, Toxicology and Pharmaceutical Science
Interferon Type I
100%
Immunosuppressive Agent
100%
Imatinib
100%
Phosphotransferase Inhibitor
66%
Neoplasm
66%
Mouse Model
33%
Malignant Neoplasm
33%
Tumor Growth
33%
Immunotherapy
33%
Gastrointestinal Stromal Tumor
33%